Helicobacter pylori Eradication Therapy: Scientific Approaches and Common Misconceptions

Introduction

Helicobacter pylori (Hp) infection affects approximately half of the global population and is a significant driver of chronic gastritis, peptic ulcers, and even gastric cancer. In China, the infection rate is about 40%-60%, with antibiotic resistance increasing year by year. Many patients have questions about eradication therapy: Should it be treated? What is the most effective approach? This article, based on the latest international guidelines (such as the Maastricht VI consensus) and clinical practice, breaks down the scientific pathway for Hp eradication.

Clear Indications for Eradication Therapy

Not all Hp-positive individuals require treatment, but eradication is strongly recommended in the following cases:

Peptic ulcers (gastric or duodenal ulcers)

Chronic gastritis with dyspeptic symptoms (bloating, abdominal pain, acid reflux, etc.)

Gastric mucosa-associated lymphoid tissue lymphoma (MALT lymphoma)

Family history of gastric cancer or after endoscopic resection of early gastric cancer

Patients on long-term proton pump inhibitors (PPIs) or aspirin

For asymptomatic young individuals with Hp infection, eradication therapy can also reduce the long-term risk of gastric cancer. Japanese studies have shown that Hp eradication can reduce gastric cancer risk by approximately 34%. Therefore, if you have chronic gastritis and test positive for Hp, it is advisable to assess the benefits of treatment.

First-Line Regimen: Bismuth-Containing Quadruple Therapy as the Mainstream

Due to clarithromycin resistance rates exceeding 20% in China, bismuth-containing quadruple therapy has been recommended as the first-line choice. A typical regimen includes:

PPI (e.g., esomeprazole) twice daily

Bismuth (e.g., bismuth potassium citrate) twice daily

Two antibiotics (e.g., amoxicillin + clarithromycin, or amoxicillin + levofloxacin, or tetracycline + metronidazole) twice daily

The treatment duration is 14 days, with eradication rates reaching 85%-95%. Compared to traditional triple therapy (PPI + two antibiotics), quadruple therapy is more effective against resistant strains, especially suitable for Chinese patients.

Key Points:

Strictly follow the prescribed medication regimen; do not miss doses or stop on your own

During treatment, you may experience a bitter taste, black stools (due to bismuth), and mild nausea, which are generally tolerable

If you are allergic to penicillin, inform your doctor to adjust the antibiotic regimen

Second-Line Strategies After Treatment Failure

The initial eradication failure rate is about 10%-20%, commonly due to antibiotic resistance or poor adherence. If treatment fails, it is recommended to:

Wait at least 3 months before rescue therapy to restore bacterial susceptibility to antibiotics

Perform drug susceptibility testing (via endoscopic biopsy or stool PCR) to guide antibiotic selection

Switch to different antibiotic combinations, such as regimens containing furazolidone or tetracycline, or use vonoprazan (a potassium-competitive acid blocker) instead of a PPI, which provides stronger acid suppression and can improve eradication rates

Internationally, for refractory infections, regimens containing rifabutin or high-dose amoxicillin are also used, but caution is needed regarding resistance and side effects.

Follow-Up Testing and Daily Prevention: Avoiding Reinfection

After completing eradication therapy, wait at least 4 weeks before follow-up testing (discontinuing PPIs and antibiotics during this period). The carbon-13/14 urea breath test is commonly used to confirm negativity. After conversion to negative, the reinfection rate in China is approximately 1%-2% per year, lower than expected, but precautions are still necessary:

Use separate serving utensils or shared chopsticks; if family members are also positive, consider treating them together

Maintain food hygiene, avoiding raw water and raw food

Keep a regular lifestyle and reduce factors that damage the gastric mucosa (such as smoking, alcohol, and NSAIDs)

If the follow-up test remains positive, bring your previous medication records and seek a gastroenterologist to develop an individualized regimen.

Recommendations for International Patients

If you are in China or planning to seek medical care here, it is recommended to:

Bring previous examination reports (such as endoscopy or breath test results) for rapid evaluation by doctors

In China, the cost of eradication therapy is relatively reasonable: including medication and tests, it ranges from 1000-3000 RMB, and you can learn more via cost estimation

Choose a reputable hospital's gastroenterology department, preferably one with a specialized Hp clinic; our Mei Jia Kang can assist in scheduling expert consultations, arranging interpretation, and follow-up care

Maintain communication with your doctor during treatment; if severe adverse reactions occur (such as rash or severe diarrhea), seek medical attention promptly

Eradicating Helicobacter pylori is a long-term battle, but a scientific approach can significantly improve success rates. Do not delay due to fear of resistance, nor ignore it because symptoms are mild. Proactive management is key to protecting gastric health. For personalized advice, feel free to contact us.